|
1）Colman RJ, Anderson RM, Johnson SC, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009; 325: 201-4
|
|
|
|
2）Burnett C, Valentini S, Cabreiro F, et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Dorsophila. Nature. 2011; 477: 482-5
|
|
|
|
|
|
3）Kaeberlein M, Kirkland KT, Fields S, et al. Sir2-independent life span extention by calorie restriction in yeast. PLoS Biol. 2004; 2: E296
|
|
|
|
|
4）Ramadori G, Fujikawa T, Fukuda M, et al. SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity. Cell Metab. 2010; 12: 78-87
|
|
|
|
|
|
5）Ramadori G, Fujikawa T, Anderson J, et al. SIRT1 deacetylase in SF1 neurons protects against metabolic imbalance. Cell Metab. 2011; 14: 301-12
|
|
|
|
|
|
6）Ramsey KM, Mills KF, Satoh A, et al. Age-associated loss of SIRT1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific SIRT1 overexpression mice. Aging Cell. 2008; 7: 78-88
|
|
|
|
|
|
7）Bastien PO, Valenti L, Kon N, et al. Glucagon-like peptide inhibits the sirtuini deacetylase SIRT1 to stimulate pancreatic beta-cell mass expansion. Diabetes. 2011; 60: 3217-22
|
|
|
|
|
|
8）Schenk S, McCurdy CE, Philp A, et al. SIRT1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction. J Ciln Invest. 2011; 121: 4281-8
|
|
|
|
|
|
9）Iwabu M, Yamauchi T, Okada-Iwabu M, et al. Adiponectin and adipoR1 regulates PGC-1 alpha and mitochondria by Ca and AMPK/SIRT1. Nature. 2010 ; 464: 1313-9
|
|
|
|
|
|
10）Purushotham A, Schug TT, Xu Q, et al. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 2009; 9: 327-33
|
|
|
|
|
|
11）Picard F, Kurtev M, Chung N, et al. SIRT1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature. 2004; 429: 771-6
|
|
|
|
|
|
12）Yoshizaki T, Milne JC, Imamura T, et al. SIRT1 exerts anti-inflammatory effects and improve insulin sensitivity in adipocytes. Mol Cell Biol. 2009; 29: 1363-74
|
|
|
|
|
|
13）Gillum MP, Kotas ME, Erion DM, et al. SIRT1 regulates adipose tissue inflammation. Diabetes. 2011; 60 : 3235-45
|
|
|
|
|
|
14）Yoshizaki T, Schenk S, Imamura T, et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab. 2010; 298: E419-28
|
|
|
|
|
|
15）Schug TT, Xu Q, Gao H, et al. Myeloid deletion of SIRT1 induces inflammatory signaling in response to enviromental stress. Mol Cell Biol. 2010; 30: 4712-21
|
|
|
|
|
|
16）Zhu H, Zhao L, Wang E, et al. The QKI-PLP pathyway controls SIRT2 abundance in CNS myelin. Glia. 2012; 60: 69-82
|
|
|
|
|
|
17）Jing E, Gesta S, Kahn CR. SIRT2 regulates adipocyte differentiation through FoxO1 acetyla-tion/deacetylation. Cell Metab. 2007; 6: 105-14
|
|
|
|
|
|
18）Jiang W, Wang S, Xiao M, et al. Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBRS ubiqutin ligase. Mol Cell. 2011; 43: 33-44
|
|
|
|
|
|
19）Hirschev MN, Shimazu T, Jing E, et al. SIRT3 deficiency and mitochondrial protein hyperacety-lation accelerate the development of the metabolic syndrome. Mol Cell. 2011; 44: 177-90
|
|
|
|
|
|
20）Ahuja N, Schwer B, Carobbio S, et al. Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem. 2007; 282: 33583-92
|
|
|
|
|
|
21）Nasrin N, Wu X, Fortier E, et al. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J Biol Chem. 2010; 285: 31995-2002
|
|
|
|
|
|
22）Schlicker C, Gertz M, Papatheodorou P, et al. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol. 2008; 3823: 790-801
|
|
|
|
|
|
23）Xiao C, Kim HS, Lahausen T, et al. SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. J Biol Chem. 2010; 285: 36776-84
|
|
|
|
|
|
24）Kanfi Y, Peshti V, Gil R, et al. SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell. 2010; 9: 162-73
|
|
|
|
|
|
25）Kanfi Y, Naiman S, Amir G, et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature. 2012; 483: 218-21
|
|
|
|
|
|
26）Yoshino J, Mills KF, Yoon MJ, et al. Nicotinamide mononucleotide, a key NAD intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011; 14: 528-36
|
|
|
|
|
|
27）Revollo JR, Korner A, Mills KF, et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 2007; 6: 363-75
|
|
|
|
|
|
28）Lagouge M, Argmann C, Gerhart A, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC1alpha. Cell. 2006; 127: 1109-22
|
|
|
|
|
|
29）Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008; 8: 157-68
|
|
|
|
|
|
30）Milne JC, Lambert PD, Schenk A, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007; 450: 712-6
|
|
|
|
|
|
31）Feige JN, Lagouge M, Canto C, et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 2008; 8: 347-58
|
|
|
|
|
|
32）Pacholec M, Bleasdale JE, Chrunky B, et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem. 2010; 285: 8340-51
|
|
|
|
|
|
33）Minor RK, Baur JA, Gomes AP, et al. SRT1720 improves survival and healthspan of obese mice. Sci Rep. 2011; 1: 70
|
|
|
|
|
|
34）Park SJ, Ahmad F, Philp A, et al. Resveratrol ameliorates aging-related metabolic phenotype by inhibiting cAMP phosphodiesterases. Cell. 2012; 148: 421-33
|
|
|
|
|
|
35）Price NL, Gomes AP, Ling AJ, et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 2012; 15: 675-90
|
|
|
|
|
|
36）Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011; 14: 612-22
|
|
|
|
|